Skip To Main Content
Určeno pro odbornou veřejnost
Campus
Campus
View Full Results

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.

Číst více

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.

Číst více

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.

Číst více

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.

Číst více

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.

Číst více

יעילות ובטיחות טוג'או בחולי סוכרת סוג 2 עם או בלי טיפול קודם ב-GLP-1 RA

Číst více

Kazuistika – inzulin u diabetičky 1. typu v průběhu gravidity a v šestinedělí

Číst více

Aktualizace SmPC přípravku Praluent

V tomto článku se dozvíte více o aktualizaci SmPC přípravku Praluent.

Číst více

Praluent - ESC/EAS Guidelines pro management dyslipidemie

Číst více

LixiLan-L Çalışması: Tokluk Kan Şekerinde Soliqua

Číst více

Primer inhibidor selectivo de ROCK2 para el tratamiento de la EICHc

Una forma innovadora y segura de tratamiento para pacientes con enfermedad de injerto contra huésped crónica. Para pacientes adultos y pediátricos de 12 años o más con EICHc después del fracaso de al menos 2 líneas previas de terapia sistémica.1

Číst více

Discover outcomes seen after starting Gla-300 in people with inadequately controlled T2DM on prior GLP-1 RA

Číst více